Samrat Associates, where our specialized US FDA Registration Service for Drugs paves the route for success in the pharmaceutical industry. It might be difficult to navigate the complexities of the US Food and Drug Administration (US FDA) approval procedure, but with our professional advice, tailored solutions, and uncompromising dedication to quality, we guarantee a smooth application to approval process.
Quality control is promoted by our service all the way through the registration procedure. We collaborate together with you to make sure your medication satisfies the exacting requirements for quality established by the US FDA, promoting trust in the security and effectiveness of your offering.
Our commitment to fulfilling the legal standards of the US and the UAE is demonstrated by our US FDA Certificate. It is an expression of our awareness of how crucial it is to follow global standards and laws while offering our clients reliable products.
Furthermore, our US FDA Registration Service for Drugs includes comprehensive support for documentation, regulatory submissions, and compliance with current Good Manufacturing Practices (cGMP). We assist in preparing Drug Master Files (DMF), ensuring proper labeling, and guiding you through each stage of the approval process. With our in-depth industry knowledge and up-to-date regulatory expertise, we help minimize delays and ensure your pharmaceutical products meet all necessary requirements for successful entry into the U.S. market.
Drug establishment registration and drug listing involve registering pharmaceutical manufacturing facilities with the FDA and listing all drug products manufactured for commercial distribution in the U.S.
Yes, all domestic and foreign establishments that manufacture, repack, or relabel drug products for distribution in the U.S. must register with the FDA annually.
An NDC number is a unique 10-digit, 3-segment numeric identifier assigned to commercial drugs in the United States during the FDA drug listing process.
Yes, foreign drug establishments must designate a U.S. Agent who resides or maintains a place of business in the U.S. for FDA regulatory communication.
Company registration details, DUNS number, establishment registration number (FEI), proprietary and non-proprietary drug names, active ingredient details, and product labeling artwork.
Drug establishment registrations must be renewed annually between October 1st and December 31st of each calendar year.
Professional guidance ensures accurate Electronic Drug Registration and Listing System (eDRLS) submissions, prevents FDA import alerts, and ensures full cGMP compliance.